Search results
Texas House approves ban on COVID-19 vaccine mandates by private employers
KRGV Rio Grande Valley· 4 days agoSign up for The Brief, The Texas Tribune’s daily newsletter that keeps readers up to speed on the...
Past COVID infections may help protect against certain colds. Could it lead to better vaccines?
WPRI Providence· 1 day agoIf you’ve been sick with COVID-19, you may have some protection against certain versions of the...
Moderna's COVID-Flu Vaccine Shows Stronger Immune Response Than Individual Shots, Late-Stage Trial...
Forbes· 4 days agoModerna on Monday said its combination COVID-19 and flu shot elicits a stronger immune response...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
AOL· 3 days agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna, which is developing the experimental vaccine ...
How a blunder by a respected medical journal is fueling an anti-vaccine lie
Los Angeles Times· 3 days agoThe paper published by the respected British Medical Journal earlier this month was eye-opening, to...
Feeling sick after your COVID shot? That means it’s working
KRON via Yahoo News· 3 days agoSAN FRANCISCO (KRON) — If you feel terrible after receiving a COVID-19 vaccine shot, that’s a...
How A New Covid-19 Antibody Could Contribute To Advanced Vaccine Development
Forbes· 7 days agoIn the ongoing Omicron era, a new Covid-19 antibody could renew optimism for urgently required...
Tucker Carlson is going on tour. Ticketmaster is profiting off his hateful rhetoric
CNN Business via Yahoo Finance· 12 hours agoCarlson lied about the Covid-19 vaccines, discouraging his fans from receiving the life-saving...
Moderna says combo COVID-flu vaccine showing promising results — and more
WGN Chicago via Yahoo News· 3 days agoNew study: 18% had lung cancer screening New research shows only a fraction of Americans are getting...
2-in-1 shot for flu and COVID shows promise in advanced trial
LiveScience· 3 days agoThe ongoing clinical trial pits this new combination shot, called mRNA-1083, against several licensed vaccines that protect against either COVID-